Education
About Us
Working with TipRanks
Follow Us
Origin Therapeutics Holdings, Inc. (TSE:SPLY)
:SPLY
SPLY Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.13
Previous CloseN/A
Volume19.00K
Average Volume (3M)84.90K
Market Cap
C$15.21M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta-0.61
Next Earnings
Sep 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding169,025,220
10 Day Avg. Volume83,599
30 Day Avg. Volume84,898
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Origin Therapeutics Holdings, Inc. News
PremiumCompany Announcements
Safe Supply CEO to Co-Chair MAHA Coalition at U.S. House
PremiumCompany Announcements
Safe Supply Streaming Co. Ltd. Appoints Geoff Benic as CEO to Drive Growth
PremiumCompany Announcements
Safe Supply Streaming Co. Ltd. Strengthens Board with New Appointments
PremiumCompany Announcements
Safe Supply Closes $791,200 Private Placement to Boost Growth
PremiumCompany Announcements
Safe Supply Streaming Co. Ltd. Strengthens Leadership and Financial Strategy
PremiumCompany Announcements
Safe Supply Completes Acquisition of Safety Strips Tech Corp.Options Prices
Currently, No data available
---
Ownership Overview
8.28% Insiders
―
Mutual Funds
― Other Institutional Investors
91.72% Public Companies and
Individual Investors
SPLY FAQ
What was Origin Therapeutics Holdings, Inc.’s price range in the past 12 months?
Origin Therapeutics Holdings, Inc. lowest stock price was C$0.01 and its highest was C$0.13 in the past 12 months.
What is Origin Therapeutics Holdings, Inc.’s market cap?
Origin Therapeutics Holdings, Inc.’s market cap is C$15.21M.
When is Origin Therapeutics Holdings, Inc.’s upcoming earnings report date?
Origin Therapeutics Holdings, Inc.’s upcoming earnings report date is Sep 02, 2025 which is in 47 days.
How were Origin Therapeutics Holdings, Inc.’s earnings last quarter?
Currently, no data Available
Is Origin Therapeutics Holdings, Inc. overvalued?
According to Wall Street analysts Origin Therapeutics Holdings, Inc.’s price is currently Overvalued.
Does Origin Therapeutics Holdings, Inc. pay dividends?
Origin Therapeutics Holdings, Inc. does not currently pay dividends.
What is Origin Therapeutics Holdings, Inc.’s EPS estimate?
Origin Therapeutics Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Origin Therapeutics Holdings, Inc. have?
Origin Therapeutics Holdings, Inc. has 169,025,220 shares outstanding.
What happened to Origin Therapeutics Holdings, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Origin Therapeutics Holdings, Inc.?
Currently, no hedge funds are holding shares in TSE:SPLY
Company Description
Origin Therapeutics Holdings, Inc.
Origin Therapeutics Holdings Inc is an investment company primarily focusing on investments in the psychedelic industry. The Company plans to invest in opportunities involving, where legally permitted, the research, design, development, testing, production, distribution and sale of psychedelics and services related thereto.
Technical Analysis
Flow Capital Corp
―
Esstra Industries
―
ESG Global Impact Capital
―
Torrent Capital Ltd
―
The Western Investment Company of Canada Ltd
―